Defective T Memory Cell Differentiation after Varicella Zoster Vaccination in Older Individuals

PLoS Pathogens

Volumn 12, Issue 10, 2016, Pages

  Qi, Qian ^a,b   Cavanagh, Mary M ^a,b   Le Saux, Sabine ^a,b   Wagar, Lisa E ^a   Mackey, Sally ^c   Hu, Jinyu ^a,b   Maecker, Holden ^a   Swan, Gary E ^a   Davis, Mark M ^a   Dekker, Cornelia L ^c   Tian, Lu ^c   Weyand, Cornelia M ^a,b   Goronzy, Jörg J ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^c STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; MALE; MEMORY T LYMPHOCYTE; MICROARRAY ANALYSIS; VACCINATION; VARICELLA ZOSTER VIRUS; DNA MICROARRAY; HERPES ZOSTER; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; MIDDLE AGED; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

VARICELLA ZOSTER VACCINE;

AGED; CELL DIFFERENTIATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; ENZYME-LINKED IMMUNOSPOT ASSAY; FEMALE; HERPES ZOSTER; HERPES ZOSTER VACCINE; HUMANS; IMMUNOLOGIC MEMORY; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES;

EID: 84992712438     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1005892     Document Type: Article

References (53)

1. Donahue JG, Choo PW, Manson JE, Platt R, The incidence of herpes zoster. Arch Intern Med. 1995;155(15):1605–9. doi: 10.1001/archinte.1995.004301500710087618983
2. Yawn BP, Saddier P, Wollan PC, St Sauver JL, Kurland MJ, Sy LS, A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc. 2007;82(11):1341–9. doi: 10.4065/82.11.134117976353
3. Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005;352(22):2271–84. doi: 10.1056/NEJMoa05101615930418
4. Tseng HF, Smith N, Harpaz R, Bialek SR, Sy LS, Jacobsen SJ, Herpes zoster vaccine in older adults and the risk of subsequent herpes zoster disease. JAMA. 2011;305(2):160–6. doi: 10.1001/jama.2010.198321224457
5. Langan SM, Smeeth L, Margolis DJ, Thomas SL, Herpes zoster vaccine effectiveness against incident herpes zoster and post-herpetic neuralgia in an older US population: a cohort study. PLoS Med. 2013;10(4):e1001420. PubMed Central PMCID: PMC3621740. doi: 10.1371/journal.pmed.100142023585738
6. Duraisingham SS, Rouphael N, Cavanagh MM, Nakaya HI, Goronzy JJ, Pulendran B, Systems biology of vaccination in the elderly. Curr Top Microbiol Immunol. 2013;363:117–42. doi: 10.1007/82_2012_25022903566
7. Tsang JS, Schwartzberg PL, Kotliarov Y, Biancotto A, Xie Z, Germain RN, et al. Global analyses of human immune variation reveal baseline predictors of postvaccination responses. Cell. 2014;157(2):499–513. PubMed Central PMCID: PMC4139290. doi: 10.1016/j.cell.2014.03.03124725414
8. Nakaya HI, Wrammert J, Lee EK, Racioppi L, Marie-Kunze S, Haining WN, et al. Systems biology of vaccination for seasonal influenza in humans. Nat Immunol. 2011;12(8):786–95. PubMed Central PMCID: PMC3140559. doi: 10.1038/ni.206721743478
9. Tan Y, Tamayo P, Nakaya H, Pulendran B, Mesirov JP, Haining WN, Gene signatures related to B-cell proliferation predict influenza vaccine-induced antibody response. Eur J Immunol. 2014;44(1):285–95. PubMed Central PMCID: PMC3973429. doi: 10.1002/eji.20134365724136404
10. Franco LM, Bucasas KL, Wells JM, Nino D, Wang X, Zapata GE, et al. Integrative genomic analysis of the human immune response to influenza vaccination. Elife. 2013;2:e00299. PubMed Central PMCID: PMC3713456. doi: 10.7554/eLife.0029923878721
11. Furman D, Jojic V, Kidd B, Shen-Orr S, Price J, Jarrell J, et al. Apoptosis and other immune biomarkers predict influenza vaccine responsiveness. Mol Syst Biol. 2013;9:659. PubMed Central PMCID: PMC3658270. doi: 10.1038/msb.2013.1523591775
12. Obermoser G, Presnell S, Domico K, Xu H, Wang Y, Anguiano E, et al. Systems scale interactive exploration reveals quantitative and qualitative differences in response to influenza and pneumococcal vaccines. Immunity. 2013;38(4):831–44. PubMed Central PMCID: PMC3681204. doi: 10.1016/j.immuni.2012.12.00823601689
13. Li S, Rouphael N, Duraisingham S, Romero-Steiner S, Presnell S, Davis C, et al. Molecular signatures of antibody responses derived from a systems biology study of five human vaccines. Nat Immunol. 2014;15(2):195–204. PubMed Central PMCID: PMC3946932. doi: 10.1038/ni.278924336226
14. Querec TD, Akondy RS, Lee EK, Cao W, Nakaya HI, Teuwen D, et al. Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nat Immunol. 2009;10(1):116–25. PubMed Central PMCID: PMC4049462. doi: 10.1038/ni.168819029902
15. Nakaya HI, Hagan T, Duraisingham SS, Lee EK, Kwissa M, Rouphael N, et al. Systems Analysis of Immunity to Influenza Vaccination across Multiple Years and in Diverse Populations Reveals Shared Molecular Signatures. Immunity. 2015;43(6):1186–98. doi: 10.1016/j.immuni.2015.11.01226682988
16. Thakar J, Mohanty S, West AP, Joshi SR, Ueda I, Wilson J, et al. Aging-dependent alterations in gene expression and a mitochondrial signature of responsiveness to human influenza vaccination. Aging. 2015;7(1):38–52. PubMed Central PMCID: PMC4356402. doi: 10.18632/aging.10072025596819
17. Levin MJ, Smith JG, Kaufhold RM, Barber D, Hayward AR, Chan CY, et al. Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccine. J Infect Dis. 2003;188(9):1336–44. doi: 10.1086/37904814593591
18. Hata A, Asanuma H, Rinki M, Sharp M, Wong RM, Blume K, et al. Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants. N Engl J Med. 2002;347(1):26–34. doi: 10.1056/NEJMoa01344112097537
19. Levin MJ, Oxman MN, Zhang JH, Johnson GR, Stanley H, Hayward AR, et al. Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine. J Infect Dis. 2008;197(6):825–35. PubMed Central PMCID: PMC4014857. doi: 10.1086/52869618419349
20. Kaech SM, Wherry EJ, Heterogeneity and cell-fate decisions in effector and memory CD8+ T cell differentiation during viral infection. Immunity. 2007;27(3):393–405. PubMed Central PMCID: PMC3431921. doi: 10.1016/j.immuni.2007.08.00717892848
21. Williams MA, Bevan MJ, Effector and memory CTL differentiation. Annu Rev Immunol. 2007;25:171–92. doi: 10.1146/annurev.immunol.25.022106.14154817129182
22. Williams MA, Ravkov EV, Bevan MJ, Rapid culling of the CD4+ T cell repertoire in the transition from effector to memory. Immunity. 2008;28(4):533–45. PubMed Central PMCID: PMC2391296. doi: 10.1016/j.immuni.2008.02.01418356084
23. van Leeuwen EM, Sprent J, Surh CD, Generation and maintenance of memory CD4(+) T Cells. Curr Opin Immunol. 2009;21(2):167–72. PubMed Central PMCID: PMC2676210. doi: 10.1016/j.coi.2009.02.00519282163
24. Araki K, Youngblood B, Ahmed R, The role of mTOR in memory CD8 T-cell differentiation. Immunol Rev. 2010;235(1):234–43. PubMed Central PMCID: PMC3760155. doi: 10.1111/j.0105-2896.2010.00898.x20536567
25. Sasaki S, He XS, Holmes TH, Dekker CL, Kemble GW, Arvin AM, et al. Influence of prior influenza vaccination on antibody and B-cell responses. PLoS One. 2008;3(8):e2975. PubMed Central PMCID: PMC2500171. doi: 10.1371/journal.pone.000297518714352
26. Shen-Orr SS, Tibshirani R, Khatri P, Bodian DL, Staedtler F, Perry NM, et al. Cell type-specific gene expression differences in complex tissues. Nat Methods. 2010;7(4):287–9. PubMed Central PMCID: PMC3699332. doi: 10.1038/nmeth.143920208531
27. Akondy RS, Monson ND, Miller JD, Edupuganti S, Teuwen D, Wu H, et al. The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response. J Immunol. 2009;183(12):7919–30. PubMed Central PMCID: PMC3374958. doi: 10.4049/jimmunol.080390319933869
28. Bertoli C, Skotheim JM, de Bruin RA, Control of cell cycle transcription during G1 and S phases. Nature reviews Molecular cell biology. 2013;14(8):518–28. PubMed Central PMCID: PMC4569015. doi: 10.1038/nrm362923877564
29. McElhaney JE, Xie D, Hager WD, Barry MB, Wang Y, Kleppinger A, et al. T cell responses are better correlates of vaccine protection in the elderly. J Immunol. 2006;176(10):6333–9. doi: 10.4049/jimmunol.176.10.633316670345
30. Sridhar S, Begom S, Bermingham A, Hoschler K, Adamson W, Carman W, et al. Cellular immune correlates of protection against symptomatic pandemic influenza. Nat Med. 2013;19(10):1305–12. doi: 10.1038/nm.335024056771
31. Wilkinson TM, Li CK, Chui CS, Huang AK, Perkins M, Liebner JC, et al. Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans. Nat Med. 2012;18(2):274–80. doi: 10.1038/nm.261222286307
32. Ahlers JD, Belyakov IM, Memories that last forever: strategies for optimizing vaccine T-cell memory. Blood. 2010;115(9):1678–89. PubMed Central PMCID: PMC2920202. doi: 10.1182/blood-2009-06-22754619903895
33. Qi Q, Cavanagh MM, Saux SL, NamKoong H, Kim C, Turgano E, et al. Diversification of the antigen-specific T cell receptor repertoire after varicella zoster vaccination. Science Translational Medicine. 2016;8(332):332ra46. doi: 10.1126/scitranslmed.aaf172527030598
34. Seder RA, Darrah PA, Roederer M, T-cell quality in memory and protection: implications for vaccine design. Nat Rev Immunol. 2008;8(4):247–58. doi: 10.1038/nri227418323851
35. Klein NP, Holmes TH, Sharp MA, Heineman TC, Schleiss MR, Bernstein DI, et al. Variability and gender differences in memory T cell immunity to varicella-zoster virus in healthy adults. Vaccine. 2006;24(33–34):5913–8. doi: 10.1016/j.vaccine.2006.04.06016759768
36. Tan PL, Jacobson RM, Poland GA, Jacobsen SJ, Pankratz VS, Twin studies of immunogenicity—determining the genetic contribution to vaccine failure. Vaccine. 2001;19(17–19):2434–9. doi: 10.1016/S0264-410X(00)00468-011257374
37. Newport MJ, Goetghebuer T, Weiss HA, Whittle H, Siegrist CA, Marchant A, et al. Genetic regulation of immune responses to vaccines in early life. Genes Immun. 2004;5(2):122–9. doi: 10.1038/sj.gene.636405114737096
38. Brodin P, Jojic V, Gao T, Bhattacharya S, Angel CJ, Furman D, et al. Variation in the human immune system is largely driven by non-heritable influences. Cell. 2015;160(1–2):37–47. PubMed Central PMCID: PMC4302727. doi: 10.1016/j.cell.2014.12.02025594173
39. Wang C, Liu Y, Cavanagh MM, Le Saux S, Qi Q, Roskin KM, et al. B-cell repertoire responses to varicella-zoster vaccination in human identical twins. Proc Natl Acad Sci U S A. 2015;112(2):500–5. PubMed Central PMCID: PMC4299233. doi: 10.1073/pnas.141587511225535378
40. Son YM, Ahn SM, Kim GR, Moon YS, Kim SH, Park YM, et al. Resistin enhances the expansion of regulatory T cells through modulation of dendritic cells. BMC Immunol. 2010;11:33. PubMed Central PMCID: PMCPMC2914082. doi: 10.1186/1471-2172-11-3320591185
41. Miller JD, van der Most RG, Akondy RS, Glidewell JT, Albott S, Masopust D, et al. Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines. Immunity. 2008;28(5):710–22. doi: 10.1016/j.immuni.2008.02.02018468462
42. Hodes RJ, Hathcock KS, Weng NP, Telomeres in T and B cells. Nat Rev Immunol. 2002;2(9):699–706. doi: 10.1038/nri89012209138
43. Sharpless NE, DePinho RA, Telomeres, stem cells, senescence, and cancer. The Journal of clinical investigation. 2004;113(2):160–8. PubMed Central PMCID: PMC311439. doi: 10.1172/JCI2076114722605
44. Goronzy JJ, Weyand CM, Understanding immunosenescence to improve responses to vaccines. Nat Immunol. 2013;14(5):428–36. PubMed Central PMCID: PMC4183346. doi: 10.1038/ni.258823598398
45. Kim C, Jay DC, Williams MA, Dynamic functional modulation of CD4+ T cell recall responses is dependent on the inflammatory environment of the secondary stimulus. PLoS Pathog. 2014;10(5):e1004137. PubMed Central PMCID: PMC4031222. doi: 10.1371/journal.ppat.100413724854337
46. Lamar DL, Weyand CM, Goronzy JJ, Promoter choice and translational repression determine cell type-specific cell surface density of the inhibitory receptor CD85j expressed on different hematopoietic lineages. Blood. 2010;115(16):3278–86. PubMed Central PMCID: PMCPMC2858479. doi: 10.1182/blood-2009-09-24349320194892
47. Mjelle R, Hegre SA, Aas PA, Slupphaug G, Drablos F, Saetrom P, et al. Cell cycle regulation of human DNA repair and chromatin remodeling genes. DNA Repair (Amst). 2015;30:53–67. doi: 10.1016/j.dnarep.2015.03.00725881042
48. Jackson SP, Bartek J, The DNA-damage response in human biology and disease. Nature. 2009;461(7267):1071–8. PubMed Central PMCID: PMC2906700. doi: 10.1038/nature0846719847258
49. Fang F, Yu M, Cavanagh MM, Hutter Saunders J, Qi Q, Ye Z, et al. Expression of CD39 on Activated T Cells Impairs their Survival in Older Individuals. Cell reports. 2016;14(5):1218–31. doi: 10.1016/j.celrep.2016.01.00226832412
50. Mannick JB, Del Giudice G, Lattanzi M, Valiante NM, Praestgaard J, Huang B, et al. mTOR inhibition improves immune function in the elderly. Sci Transl Med. 2014;6(268):268ra179. doi: 10.1126/scitranslmed.300989225540326
51. Krasnow RE, Jack LM, Lessov-Schlaggar CN, Bergen AW, Swan GE, The Twin Research Registry at SRI International. Twin Res Hum Genet. 2013;16(1):463–70. doi: 10.1017/thg.2012.8123084148
52. Abbas AR, Wolslegel K, Seshasayee D, Modrusan Z, Clark HF, Deconvolution of blood microarray data identifies cellular activation patterns in systemic lupus erythematosus. PloS one. 2009;4(7):e6098. PubMed Central PMCID: PMC2699551. doi: 10.1371/journal.pone.000609819568420
53. Gu Z, Gu L, Eils R, Schlesner M, Brors B, circlize implements and enhances circular visualization in R. Bioinformatics. 2014;30(19):2811–2. doi: 10.1093/bioinformatics/btu39324930139